Jiancheng Zhou

Xi'an, 710061, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications

Corrigendum to "DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling" [Cellular Signaling, 2015 Sep 26; 27(12): 2515-2523].

Corrigendum to "DAB2IP regulates the chemoresistance to pirarubicin and tumor recurrence of non-muscle invasive bladder cancer through STAT3/Twist1/P-glycoprotein signaling" [Cellular Signaling, 2015 Sep 26; 27(12): 2515-2523].

Journal: Cellular signalling
Published: July 14, 2026

Correction: Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs.

Correction: Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs.

Journal: Cell death & disease
Published: June 08, 2026

Association of magnesium depletion score with increased prevalence of erectile dysfunction and risks of all-cause and cardiovascular disease mortality.

Association of magnesium depletion score with increased prevalence of erectile dysfunction and risks of all-cause and cardiovascular disease mortality.

Journal: The journal of sexual medicine
Published: June 05, 2025

SETD7 Promotes Cell Proliferation and Migration via Methylation-mediated TAF7 in Clear Cell Renal Cell Carcinoma.

SETD7 Promotes Cell Proliferation and Migration via Methylation-mediated TAF7 in Clear Cell Renal Cell Carcinoma.

Journal: International journal of biological sciences
Published: December 13, 2023

DAB2IP stabilizes p27Kip1 via suppressing PI3K/AKT signaling in clear cell renal cell carcinoma.

DAB2IP stabilizes p27Kip1 via suppressing PI3K/AKT signaling in clear cell renal cell carcinoma.

Journal: Functional & integrative genomics
Published: July 27, 2023

NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway.

NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway.

Journal: Evidence-based complementary and alternative medicine : eCAM
Published: July 15, 2022

The impact of genetic variants in the CYP2C8 gene on bladder cancer susceptibility.

The impact of genetic variants in the CYP2C8 gene on bladder cancer susceptibility.

Journal: Frontiers in endocrinology
Published: July 08, 2022

PYCR1 promotes bladder cancer by affecting the Akt/Wnt/β-catenin signaling.

PYCR1 promotes bladder cancer by affecting the Akt/Wnt/β-catenin signaling.

Journal: Journal of bioenergetics and biomembranes
Published: November 02, 2020

The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes.

The network of DAB2IP-miR-138 in regulating drug resistance of renal cell carcinoma associated with stem-like phenotypes.

Journal: Oncotarget
Published: March 21, 2017

Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs.

Targeting 3-phosphoinositide-dependent protein kinase 1 associated with drug-resistant renal cell carcinoma using new oridonin analogs.

Journal: Cell death & disease
Published: November 26, 2016

Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues.

Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues.

Journal: Oncotarget
Published: May 11, 2016

SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.

SPOP promotes tumor progression via activation of β-catenin/TCF4 complex in clear cell renal cell carcinoma.

Journal: International journal of oncology
Published: May 02, 2016
Showing 1-12 of 29

Last Updated: 09/26/2026